SEATTLE — June 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news. If you are covering news at the annual meeting of the American Society of Clinical Oncology (June 4-8), check out our ASCO page highlighting Fred Hutch presentations and feel free to reach out to our media team for help sourcing experts: [email protected]
A new deep-learning model that can predict how human genes and medicines will interact has identified at least 10 compounds that may hold promise as treatments for COVID-19.
Using advanced computational simulations, researchers at the University of Chicago have revealed just how remdesivir works at the molecular level, and also found that two drugs that work in a similar manner, ribavirin and favilavir, do not bind as effectively to the virus.
A new potential therapy for COVID-19 developed by researchers at Rush University Medical Center has shown success in preventing the disease’s symptoms in mice.
Throughout the COVID-19 pandemic, Rush University Medical Center has been a leader in the Chicago area in developing, expanding and evolving testing efforts. On Friday, Nov. 13, the Medical Center performed its 100,000th test for COVID-19.
George Washington University researchers found five biomarkers associated with higher odds of clinical deterioration and death in COVID-19 patients. Published in Future Medicine, these findings will help physicians better predict outcomes for COVID-19 patients in the U.S.